The role of MMP-9 in the development of CCC was demonstrated in a clinical trial, that showed a significant increase in MMP-9 in chagasic patients with EKG abnormalities and dilated cardiomyopathy (Bautista-López et al., 2013). This evidence concerns the gene MMP9 and dilated cardiomyopathy.